L-Enantiomers of transition state analogue inhibitors bound to human purine nucleoside phosphorylase. 2008

Agnes Rinaldo-Matthis, and Andrew S Murkin, and Udupi A Ramagopal, and Keith Clinch, and Simon P H Mee, and Gary B Evans, and Peter C Tyler, and Richard H Furneaux, and Steven C Almo, and Vern L Schramm
Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

Human purine nucleoside phosphorylase (PNP) was crystallized with transition-state analogue inhibitors Immucillin-H and DADMe-Immucillin-H synthesized with ribosyl mimics of l-stereochemistry. The inhibitors demonstrate that major driving forces for tight binding of these analogues are the leaving group interaction and the cationic mimicry of the transition state, even though large geometric changes occur with d-Immucillins and l-Immucillins bound to human PNP.

UI MeSH Term Description Entries
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011683 Purine-Nucleoside Phosphorylase An enzyme that catalyzes the reaction between a purine nucleoside and orthophosphate to form a free purine plus ribose-5-phosphate. EC 2.4.2.1. Inosine Phosphorylase,Nicotinamide Riboside Phosphorylase,Purine Nucleoside Phosphorylases,Nucleoside Phosphorylases, Purine,Phosphorylase, Inosine,Phosphorylase, Nicotinamide Riboside,Phosphorylase, Purine-Nucleoside,Phosphorylases, Purine Nucleoside,Purine Nucleoside Phosphorylase,Riboside Phosphorylase, Nicotinamide
D011684 Purine Nucleosides Purines with a RIBOSE attached that can be phosphorylated to PURINE NUCLEOTIDES. Purine Nucleoside,Nucleoside, Purine,Nucleosides, Purine
D011744 Pyrimidinones Heterocyclic compounds known as 2-pyrimidones (or 2-hydroxypyrimidines) and 4-pyrimidones (or 4-hydroxypyrimidines) with the general formula C4H4N2O. Pyrimidinone,Pyrimidone,Pyrimidones
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities
D018360 Crystallography, X-Ray The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) X-Ray Crystallography,Crystallography, X Ray,Crystallography, Xray,X Ray Crystallography,Xray Crystallography,Crystallographies, X Ray,X Ray Crystallographies

Related Publications

Agnes Rinaldo-Matthis, and Andrew S Murkin, and Udupi A Ramagopal, and Keith Clinch, and Simon P H Mee, and Gary B Evans, and Peter C Tyler, and Richard H Furneaux, and Steven C Almo, and Vern L Schramm
February 2002, The Journal of biological chemistry,
Agnes Rinaldo-Matthis, and Andrew S Murkin, and Udupi A Ramagopal, and Keith Clinch, and Simon P H Mee, and Gary B Evans, and Peter C Tyler, and Richard H Furneaux, and Steven C Almo, and Vern L Schramm
January 2003, Journal of medicinal chemistry,
Agnes Rinaldo-Matthis, and Andrew S Murkin, and Udupi A Ramagopal, and Keith Clinch, and Simon P H Mee, and Gary B Evans, and Peter C Tyler, and Richard H Furneaux, and Steven C Almo, and Vern L Schramm
August 2003, The Journal of biological chemistry,
Agnes Rinaldo-Matthis, and Andrew S Murkin, and Udupi A Ramagopal, and Keith Clinch, and Simon P H Mee, and Gary B Evans, and Peter C Tyler, and Richard H Furneaux, and Steven C Almo, and Vern L Schramm
February 1990, The Journal of biological chemistry,
Agnes Rinaldo-Matthis, and Andrew S Murkin, and Udupi A Ramagopal, and Keith Clinch, and Simon P H Mee, and Gary B Evans, and Peter C Tyler, and Richard H Furneaux, and Steven C Almo, and Vern L Schramm
March 2006, Organic & biomolecular chemistry,
Agnes Rinaldo-Matthis, and Andrew S Murkin, and Udupi A Ramagopal, and Keith Clinch, and Simon P H Mee, and Gary B Evans, and Peter C Tyler, and Richard H Furneaux, and Steven C Almo, and Vern L Schramm
June 1991, Biochemical pharmacology,
Agnes Rinaldo-Matthis, and Andrew S Murkin, and Udupi A Ramagopal, and Keith Clinch, and Simon P H Mee, and Gary B Evans, and Peter C Tyler, and Richard H Furneaux, and Steven C Almo, and Vern L Schramm
June 1998, Biochemistry,
Agnes Rinaldo-Matthis, and Andrew S Murkin, and Udupi A Ramagopal, and Keith Clinch, and Simon P H Mee, and Gary B Evans, and Peter C Tyler, and Richard H Furneaux, and Steven C Almo, and Vern L Schramm
March 2010, Proceedings of the National Academy of Sciences of the United States of America,
Agnes Rinaldo-Matthis, and Andrew S Murkin, and Udupi A Ramagopal, and Keith Clinch, and Simon P H Mee, and Gary B Evans, and Peter C Tyler, and Richard H Furneaux, and Steven C Almo, and Vern L Schramm
February 2008, Biochemistry,
Agnes Rinaldo-Matthis, and Andrew S Murkin, and Udupi A Ramagopal, and Keith Clinch, and Simon P H Mee, and Gary B Evans, and Peter C Tyler, and Richard H Furneaux, and Steven C Almo, and Vern L Schramm
December 2002, Biochemistry,
Copied contents to your clipboard!